Results 171 to 180 of about 6,141,684 (256)

In Vitro Evaluation of the Efficacy of Liquid Platelet‐Rich Fibrin (PRF) for Maintaining and Restoring Periodontal Ligament Cell Viability in Avulsed Teeth After 3 and 4 h of Extra‐Alveolar Dry Time

Dental Traumatology, EarlyView.
ABSTRACT Background/Aim This in vitro study evaluated whether liquid platelet‐rich fibrin could maintain or recover periodontal ligament cell viability in extracted human teeth after three and four hours of dry extra‐alveolar time. Material and Methods Sixty‐six erupted third molars with complete root formation were allocated to four groups: three‐hour
Tatiana Carvalho Kowaltschuk, Mariana Martins Juglair, Daniel Grigolo, Fabiane Barchiki, Lorena Bortolini Navarro, Everdan Carneiro, Vânia Portela Ditzel Westphalen   +6 more
wiley   +1 more source

Nutritional Impact of High-Dose Melphalan in Autologous Stem Cell Transplantation. [PDF]

Cureus
El Ouafa Y, Fadi M, Benrahma H, Bouanani N.   +3 more
europepmc   +1 more source

The future of autologous stem cell transplantation in systemic sclerosis

Autologous haematopoietic stem cell transplantation revolutionized the treatment of severe systemic sclerosis as the first therapy able to induce long-term remission in this relentlessly fibrosing disease.
Regenerative Medicine and Stem Cells, MS Reumatologie/Immunologie/Infectie, Schimmel, Charlotte, Spierings, Julia, Lab Reumatologie/Klinische Immunologie, Infection & Immunity   +5 more
core  

SKY92 Identifies High‐Risk Newly Diagnosed Multiple Myeloma With Inferior Progression‐Free Survival and Implicates NUF2 as a Candidate Driver

European Journal of Haematology, EarlyView.
ABSTRACT Objectives To determine the prevalence and prognostic significance of the SKY92 gene‐expression signature, evaluate minimal/measurable residual disease (MRD), and identify molecular drivers of high‐risk disease in transplant‐eligible newly diagnosed multiple myeloma (TE‐NDMM) patients in the Republic of Ireland.
Roisin M. McAvera, Izabela Cymer, John Quinn, Phillip T. Murphy, Patrick Thornton, Niamh McAuley, Harmony Black, Omar Abdelzaher, Catherine Duane, Tatiana Cichocka, Eva Szegezdi, Meegahage Perera, Gerard M. Crotty, Michelle Connolly, Aileen Walsh, Ruth Clifford, Janusz Krawczyk, Teresa Meenaghan, Vitaliy Mykytiv, Ezzat Elhassadi, Mark Coyne, Robert J. Cummins, Rowan Kuiper, Michael O'Dwyer, Siobhan V. Glavey   +24 more
wiley   +1 more source

Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma. [PDF]

Blood Cancer J
Yohannan B, Langworthy BW, Turner LE, Dispenzieri A, Buadi FK, Dingli D, Leung N, Kapoor P, Gonsalves WI, Kourelis T, Cook J, Binder M, Hayman SR, Lin Y, Go RS, Warsame RM, Rajkumar SV, Kumar S, Muchtar E, Alkhateeb HB, Hogan WJ, Matin A, Patnaik MM, Al-Kali A, Mangaonkar AA, Torghabeh M H, Wolf RC, Shah MV, Gertz MA.   +28 more
europepmc   +1 more source

Impact of Intensified Chemoimmunotherapy Regimens in Aggressive Non‐Hodgkin Lymphoma on Reproduction Patterns

European Journal of Haematology, EarlyView.
ABSTRACT Concerns about treatment‐related fertility impairment are common among young adult lymphoma survivors. Evidence on the impact of treatment for aggressive non‐Hodgkin lymphoma (NHL) on future childbearing is limited, although many individuals of reproductive age are affected.
Stefanie Antonilli, Anna Marklund, Joshua Entrop, Caroline E. Dietrich, Ingrid Glimelius, Tarec C. El‐Galaly, Alexander Fosså, Harald Holte, Karin E. Smedby, Knut B. Smeland, Sandra Eloranta   +10 more
wiley   +1 more source

Immunoglobulin A Subtype and Survival After Upfront Autologous Stem Cell Transplantation in Multiple Myeloma: A Real-World Cohort from the Bortezomib Era. [PDF]

Cancers (Basel)
Güllü Koca T, Koca N, Hunutlu FÇ, Yanık AM, Çubukçu S, Yılmaz R, Ersal T, Gürsoy V, Pınar İE, Özkocaman V, Özkalemkaş F.   +10 more
europepmc   +1 more source

Treatment Patterns, Outcomes and Survival Trends in T‐Cell Prolymphocytic Leukemia: A Nationwide Population‐Based Study in the Netherlands

European Journal of Haematology, EarlyView.
ABSTRACT Background T‐cell prolymphocytic leukemia (T‐PLL) is a rare, aggressive mature T‐cell malignancy with limited therapeutic options. Alemtuzumab remains the backbone of therapy, and fit responders are consolidated with allogeneic stem cell transplantation (alloSCT). However, contemporary population‐level outcomes remain poorly defined.
Mirian Brink, Arie C. van der Spek, Jeanette K. Doorduijn, Koen de Heer, Sabina Kersting, Lidwine W. Tick, Doreen G. te Raa, Hanneke M. van der Straaten, Gerrit Jan Veldhuis, Laurens Laterveer, Rogier Mous, Mark‐David Levin, Kees Meijer, Andre Mulder, M. Nijland, Gerwin Huls, Arnon P. Kater, Mar Bellido   +17 more
wiley   +1 more source

Case Report: Autologous stem cell transplantation in a patient diagnosed with AL amyloidosis in Kazakhstan. [PDF]

Front Oncol
Kolesnikova O, Kemaykin V, Burkitbayev Z, Karabekov A, Kolesnev A, Ainabay A, Ruzal V, Yusupova M, Shokubaeva F, Tursyn A, Kuanysh Z.   +10 more
europepmc   +1 more source

Transplantation Strategies in Treatment of Primary Plasma Cell Leukemia in Germany—A Multi‐Center Analysis

European Journal of Haematology, EarlyView.
ABSTRACT Objectives Primary plasma cell leukemia (pPCL) is a rare disease with poor outcomes. As data on randomized phase‐III trials are lacking, treatment recommendations are predominately based on retrospective analyses incorporating time periods with outdated therapies. Thus, the optimal consolidation strategy remains to be defined.
Maria Dampmann, Sarah Flossdorf, Julius Keyl, Theo Leitner, Cyrus Khandanpour, Markus Maulhardt, Evgenii Shumilov, Matthias Stelljes, Lisa Leypoldt, Marie Harzer, Christoph Schaefers, Francis Ayuketang Ayuk, Bastian von Tresckow, Amelie Boquoi, Thomas Schroeder, Hans Christian Reinhardt, Christine Hanoun   +16 more
wiley   +1 more source